Refine Results
- 必威体育赛事投注
- Applications and Industries
- Content Type
- Analysis Technique
- Analyzed With
- Chemical Group
- Compounds
- Detection Technique
- Injection Technique
- Instrument
- Analysis Platform
- Language
- Publication Date
1 - 20 of 75 results
Applied Filters
必威体育登录手机This technical overview demonstrates how an Agilent 1260 Infinity II Online LC can be used in combination with the Flownamics SegFlow S3 and SampleMod modules for sampling from a bioreactor.
必威体育登录手机Molecular weight confirmation and simple characterization workflows for synthetic oligos with Agilent LC/MSD XT and MS Spectral Deconvolution feature in OpenLab CDS 2.8.
必威体育登录手机This application note describes the determination of mRNA capping using a PEEK-lined diol HILIC column installed on a 1290 Infinity II Bio LC System and hyphenated with an Agilent 6545 LC/Q-TOF.
This application note demonstrates the capability of monitoring the degradation of a monoclonal antibody (mAb) during production in a bioreactor.
必威体育登录手机In this application note, the sensitive quantification of PFAS by LC/MS is described, using the Agilent 1260 Infinity II hybrid multisampler.
必威体育赛事投注In this application note, a method was presented to quantify major components as well as degradation products of lithium-ion battery electrolytes, with particular attention to achieving separation of all analytes within 14 minutes.
必威体育登录手机The advantage of using the Agilent 1290 Infinity II Bio LC System with the Agilent InfinityLab LC/MSD iQ for these challenging analytes is demonstrated.
必威体育登录手机This application note demonstrates the use of the Agilent 1260 Infinity II Hybrid Multisampler in Agilent Feed Injection mode for the multiresidue LC/MS analysis of polar pesticides dissolved in strong eluting organic solvent.
In this application note, a column screening method is demonstrated for the analysis of the four components of the Pfizer–BioNTech vaccine (BNT162b2).
必威体育登录手机In this application note, we demonstrate that the Agilent Thermal Equilibration Device (TED) combined with the biocompatible Agilent 1290 Infinity II Bio LC is the perfect setup for in-depth analysis of oligonucleotides.
必威体育登录手机In this application note, we show that method transfer can be easy and convenient with the new Agilent 1290 Infinity II Bio LC System.
必威体育登录手机This application note demonstrates the reliable separation of 2-AB- and InstantPC-labeled glycans with the Agilent 1290 Infinity II Bio LC System under resolution- and speed-optimized conditions.
必威体育登录手机In this application note, we developed LC methods for oligonucleotide raw material analysis based on the biocompatible Agilent 1290 Infinity II Bio LC.
必威体育登录手机This application note demonstrates the drug-to-antibody (DAR) determination of brentuximab vedotin using a ternary gradient with the Agilent Infinity II Prime Bio LC.
This Application Note describes a routine analysis workflow for pharmaceutical QA/QC labs.
| Korean (Korea) | Complete (PDF) |
|---|
必威体育登录手机This application note demonstrates the superior resolution in size exclusion chromatography (SEC) protein separation made possible by the Agilent 1290 Infinity II Bio LC System equipped with the Agilent AdvanceBio SEC column and ultralow dispersion...
This application note demonstrates the DAR determination of brentuximab vedotin using HIC.
必威体育登录手机In this application note, we present the new Agilent 1290 Infinity II Bio LC as the system of choice for peptide mapping.
The detection of low-level impurities contained in a sample of a structurally related main compound using high‑resolution sampling 2D-LC is shown.
| Japanese (Japan) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
| Korean (Korea) | Complete (PDF) |
必威体育登录手机In this application note, we employed an Agilent Infinity II 1260 Prime LC System coupled to an Agilent InfinityLab LC/MSD iQ for the analysis of CBD oil products manufactured for the pet industry.Here, we demonstrate excellent chromatographic...
| Korean (Korea) | Complete (PDF) |
|---|---|
| Chinese (Simplified) (China) | Complete (PDF) |
| Japanese (Japan) | Complete (PDF) |